Patent Assignment
Reel/Frame 033155/0501
Assignment of Assignor's Interest
Recorded: 2014-06-23
Pages: 4
Assignee
FRED HUTCHINSON CANCER RESEARCH CENTER
1100 FAIRVIEW AVENUE NORTH, SEATTLE, WASHINGTON, 98109
Covered Properties
(2)
Methods and Compositions Involving NKG2D Inhibitors and Cancer
Patent:
10,040,853 →
Application:
14/343,543 →
Publication:
US 2014/0377266
PCT:
PCT/US2012/054214 ↗
Methods and Compositions Involving NKG2D Inhibitors and Cancer
Application:
61/533,061 →
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Confirmatory License
Dec 20, 2016
From: FRED HUTCHINSON CANCER RESEARCH CENTER
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 041032/0878 →
Merger and Change of Name
Jun 23, 2022
From: FRED HUTCHINSON CANCER RESEARCH CENTER; SEATTLE CANCER CARE ALLIANCE
To: FRED HUTCHINSON CANCER CENTER
Reel/Frame 060439/0279 →
Corrective Assignment to Correct the Patent Application Number 63/242,906 Previously Recorded on Reel 060439 Frame 0279. Assignor(S) Hereby Confirms the Merger and Change of Name.
Nov 4, 2022
From: FRED HUTCHINSON CANCER RESEARCH CENTER; SEATTLE CANCER CARE ALLIANCE
To: FRED HUTCHINSON CANCER CENTER
Reel/Frame 061847/0594 →